Subscribe to RSS
DOI: 10.1055/s-0029-1216640
Synthesis of Fluorinated Pyrrolo[2,3-b]pyridine and Pyrrolo[2,3-d]pyrimidine Nucleosides
Publication History
Publication Date:
12 May 2009 (online)

Abstract
With the purpose of synthesizing novel ADAs (adenosine deaminase) and IMPDH (inosine 5′-monophosphate dehydrogenase) inhibitors the reactions of 5-amino-1-tert-butyl-1-H-pyrrole-3-carbonitrile with fluorinated 1,3- -bielectrophiles were studied. An efficient and convenient synthetical approach to fluorinated pyrrolo[2,3-b]pyridines was developed. The tert-butyl protecting group was successfully removed by treating the pyrrolopyridines or -pyrimidines with 60% sulfuric acid and this was followed by direct glycosylation of the products.
Key words
pyrrole - amine - fluorine - pyridine - annulation - electrophilic aromatic substitution
- 1a
Ugarkar BG.DaRe JM.Kopcho JJ.Browne CE.Schanzer JM.Wiesner JB.Erion MD. J. Med. Chem. 2000, 43: 2883Reference Ris Wihthout Link - 1b
Erion MD.Ugarkar BG.DaRe JM.Castellino AJ.Fujitaki JM.Dixon R.Appleman JR.Wiesner JB. Nucleosides, Nucleotides Nucleic Acids 1997, 16: 1013Reference Ris Wihthout Link - 2a
Seela F.Zulauf M. Nucleosides, Nucleotides Nucleic Acids 1999, 18: 2697Reference Ris Wihthout Link - 2b
Renau TE.Kennedy C.Ptak RG.Breitenbach JM.Drach JC.Townsend LB. J. Med. Chem. 1996, 39: 3470Reference Ris Wihthout Link - 2c
Crawczyk SH.Renau TE.Nassiri MR.Westerman AC.Wotring LL.Drach JC.Townsend LB. J. Med. Chem. 1995, 38: 4115Reference Ris Wihthout Link - 2d
Crawczyk SH.Nassiri MR.Kucera LS.Kern ER.Ptak RG.Wotring LL.Drach JC.Townsend LB. J. Med. Chem. 1995, 38: 4106Reference Ris Wihthout Link - 3a
Nekhai1 S.Bhat UG.Ammosova1 T.Radhakrishnan SK.Jerebtsova M.Niu X.Foster A.Layden TJ.Gartel AL. Oncogene 2007, 26: 3899Reference Ris Wihthout Link - 3b
Mohapatra S, andPledger WJ. inventors; US 2007,238,745. ; Chem. Abstr. 2007, 147, 420059Reference Ris Wihthout Link - 3c
Fujiwara Y.Hosokawa Y.Watanabe K.Tanimura S.Ozaki K.-I.Kohno M. Mol. Cancer Ther. 2007, 6: 1133Reference Ris Wihthout Link - 4a
Porcari AR.Ptak RG.Borysko KZ.Breitenbach JM.Drach JC.Townsend L. J. Med. Chem. 2000, 43: 2457Reference Ris Wihthout Link - 4b
Gartel AL, andRadhakrishnan SK. inventors; WO 2006,116,512. ; Chem. Abstr. 2006, 145, 465765Reference Ris Wihthout Link - 4c
Gordon RK.Ginalski K.Rudnicki WR.Rychlewski L.Pankaskie MC.Bujnicki JM.Chiang PK. Eur. J. Biochem. 2003, 270: 3507Reference Ris Wihthout Link - 5a
Mekouar K,Deziel R,Mounir S, andIyer RP. inventors; WO 03,055,896. ; Chem. Abstr. 2003, 139, 53249Reference Ris Wihthout Link - 5b
Schul W.Liu W.Xu H.-Y.Flamand M.Vasudevan SG. J. Infect. Dis. 2007, 195: 665Reference Ris Wihthout Link - 5c
Maccoss M,Olsen DB,Leone J, andDurette PL. inventors; WO 2006,065,335. ; Chem. Abstr. 2006, 145, 76603Reference Ris Wihthout Link - 5d
Maccoss M, andOlsen DB. inventors; WO 2006,012,078. ; Chem. Abstr. 2006, 144, 192451Reference Ris Wihthout Link - 6a
Hoffman K.Holmes FA.Fraschini G.Esparza L.Frye D.Raber MN.Newman RA.Hortobagyi GN. Cancer Chemother. Pharmacol. 1996, 37: 254Reference Ris Wihthout Link - 6b
O’Connell MJ.Rubin J.Hahn RG.Kvols LK.Moertel CG. Cancer Treat. Rep. 1987, 71: 333Reference Ris Wihthout Link - 6c
Lyss AP.Morrell LE.Perry MC. Proc. Am. Soc. Clin. Oncol. 1991, 10: 120Reference Ris Wihthout Link - 6d
Feun LG.Blessing JA.Barrett RJ.Hanjani PA. Am. J. Clin. Oncol. 1993, 16: 506Reference Ris Wihthout Link - 7
Mantovanini M,Melillo G, andDaffonchio L. inventors; WO 9,504,742. ; Chem. Abstr. 1995, 122, 314537Reference Ris Wihthout Link - 8
Easterwood LM.Veliz EA.Beal PA. J. Am. Chem. Soc. 2000, 122: 11537 - 9
Veliz EA.Easterwood LM.Beal PA. J. Am. Chem. Soc. 2003, 125: 10867 - 10
Cristalli G.Eleuteri A.Vittori S.Volpini R.Camaioni E.Lupidi G. Drug Dev. Res. 1993, 28: 253 - 11a
Lupidi G.Marmocchi F.Cristalli G. Biochem. Mol. Biol. 1998, 46: 1071Reference Ris Wihthout Link - 11b
Lupidi G.Cristalli G.Marmocchi F.Riva F.Grifantini M. J. Enzyme Inhib. Med. Chem. 1985, 1: 67Reference Ris Wihthout Link - 11c
Okamoto A.Tanaka K.Saito I. Bioorg. Med. Chem. Lett. 2002, 12: 97Reference Ris Wihthout Link - 12
Erion MD.Reddy MR. J. Am. Chem. Soc. 1998, 120: 3295 - 13a
Begue J.-P.Bonnet-Delpon D. Chemie Bioorganique et Medicinal du Fluor EDP Sciences; Paris: 2005. p.366Reference Ris Wihthout Link - 13b
Silverman RB. The Organic Chemistry of Drug Design and Drug Action 2nd Ed.: Elsevier Academic Press; Amsterdam: 2004. p.617Reference Ris Wihthout Link - 14
Agarwal RP.Spector T.Parks RE. Biochem. Pharmacol. 1977, 26: 359 - 15a
Iaroshenko VO.Volochnyuk DM.Wang Y.Vovk MV.Boiko VJ.Rusanov EB.Groth UM.Tolmachev AO. Synthesis 2007, 3309Reference Ris Wihthout Link - 15b
Iaroshenko VO.Groth U.Kryvokhyzha NV.Obeid S.Tolmachev AA.Wesch T. Synlett 2008, 343Reference Ris Wihthout Link - 15c
Volochnyuk DM.Pushechnikov AO.Krotko DG.Sibgatulin DA.Kovalyova SA.Tolmachev AA. Synthesis 2003, 1531Reference Ris Wihthout Link - 15d
Vovk MV.Bolbut AV.Boiko VI.Pirozhenko VV.Chernega AN.Tolmachev AA. Chem. Heterocycl. Compd. (Engl. Transl.) 2004, 40: 370Reference Ris Wihthout Link - 15e
Vovk MV.Bol’but AV.Dorokhov VI.Pyrozhenko VV. Synth. Commun. 2002, 32: 3749Reference Ris Wihthout Link - 15f
Iaroshenko VO.Volochnyuk DM.Kryvokhyzha NV.Martyloga A.Sevenard DV.Groth U.Brand J.Chernega AN.Shivanyuk AN.Tolmachev AA. Synthesis 2008, 2337Reference Ris Wihthout Link - 16
De Rosa M.Issac RP.Houghton G. Tetrahedron Lett. 1995, 36: 9261 - 17
Allegretti M.Anacardio R.Cesta MC.Curti R.Mantovanini M.Nano G.Topai A.Zampella Gi. Org. Process Res. Dev. 2003, 7: 209 - 18a
Brodrick A.Wibberley DG. J. Chem. Soc., Perkin Trans. 1 1975, 1910Reference Ris Wihthout Link - 18b
Benoit R.Dupas G.Bourguignon J.Queguiner G. Synthesis 1987, 1124Reference Ris Wihthout Link - 19a
Zanatta N.Amaral SS.Esteves-Souza A.Echevarria A.Brondani PB.Flores DC.Bonacorso HG.Flores AFC.Martins MAP. Synthesis 2006, 2305Reference Ris Wihthout Link - 19b
Kondratov IS.Gerus II.Kacharov AD.Gorbunova MG.Kukhar VP.Froehlich R. J. Fluorine Chem. 2005, 126: 543Reference Ris Wihthout Link - 19c
Matsumoto N.Takahashi M. Tetrahedron Lett. 2005, 46: 5551Reference Ris Wihthout Link - 20a
Dang Q.Brown BS.Erion MD. J. Org. Chem. 1996, 61: 5204Reference Ris Wihthout Link - 20b
Dang Q.Gomez-Galeno JE. J. Org. Chem. 2002, 67: 8703Reference Ris Wihthout Link - 20c
Dang Q.Liu Y.Erion MD. J. Am. Chem. Soc. 1999, 121: 5833Reference Ris Wihthout Link - 21
Vorbruggen H.Ruh-Pohlenz C. Handbook of Nucleoside Synthesis John Wiley & Sons; Chichester: 2001. - 22a
Reid JC.Calvin M. J. Am. Chem. Soc. 1950, 72: 2948Reference Ris Wihthout Link - 22b
Park JD.Brown HA.Lacher JR. J. Am. Chem. Soc. 1953, 75: 4753Reference Ris Wihthout Link - 22c
Pashkevich KI.Khomutov OG.Sevenard DV. Russ. J. Org. Chem. 1998, 34: 1727 ; Zh. Org. Khim. 1998, 34, 1798Reference Ris Wihthout Link - 22d
Sevenard DV.Lork E. J. Fluorine Chem. 2004, 125: 125Reference Ris Wihthout Link
References
Crystallographic data (excluding structure
factors) for the structures reported in this paper have been deposited
with the Cambridge Crystallographic Data Centre as supplementary publication
no. CCDC 703680 and CCDC 683574 can be obtained free of charge on
application to CCDC, 12 Union Road, Cambridge CB2 1EZ, UK [fax: +44(1223)336033;
e-mail:
deposit@ccdc.cam.ac.uk.